SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
5.14
-0.06 (-1.15%)
Mar 20, 2026, 9:55 AM EDT - Market open
SLS Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$10.00
Upside
+94.55%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +94.55% | Mar 12, 2026 |
| Maxim Group | Maxim Group | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +36.19% | Jul 16, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -41.63% | Nov 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -41.63% | Sep 7, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +55.64% | Nov 15, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +16.73% | Jun 28, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $18 | Buy | Initiates | $18 | +250.19% | Jul 21, 2021 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $12 | Hold → Strong Buy | Upgrades | $12 | +133.46% | Nov 15, 2019 |
| Oppenheimer | Oppenheimer | Buy Initiates $650 | Buy | Initiates | $650 | +12,545.91% | Nov 1, 2018 |
| Maxim Group | Maxim Group | Strong Buy Maintains $650 → $250 | Strong Buy | Maintains | $650 → $250 | +4,763.81% | Jul 20, 2018 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 19, 2018 |